Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]

Powles, T., Paterson, A., McCloskey, E. orcid.org/0000-0003-0177-8140 et al. (7 more authors) (2006) Reduction in bone relapse and improved survival with oral clodronate for adjuvant treatment of operable breast cancer [ISRCTN83688026]. Breast Cancer Research, 8 (2). R13. ISSN 1465-5411

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © Powles et al.; licensee BioMed Central Ltd. 2006 This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Bone Metastasis; Ibandronate; Visceral Metastasis; Placebo Patient; Oral Clodronate
Dates:
  • Published: 15 March 2006
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 23 May 2018 08:26
Last Modified: 23 May 2018 08:26
Published Version: https://doi.org/10.1186/bcr1384
Status: Published
Publisher: BioMed Central
Refereed: Yes
Identification Number: https://doi.org/10.1186/bcr1384
Related URLs:

Share / Export

Statistics